Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D A Handley

Showing results (51-60 of 69) with videos related to

Pageof 7
Sort By:
Mycologia|January 1, 1977
Strains of Fusidia which can be mistaken for ActinomycetesH Lechevalier, M P Lechevalier, D A Handley, et al.
Biochimica Et Biophysica Acta|April 15, 1988
Membrane-bound lipoprotein lipase on human monocyte-derived macrophages: localization by immunocolloidal gold techniqueI J Goldberg, D A Handley, T Vanni, et al.
Journal of Ultrastructure Research|April 1, 1983
Ultrastructural visualization of low-density lipoproteins during receptor binding and cellular endocytosisD A Handley, C M Arbeeny, L D Witte, et al.
Journal of Medicinal Chemistry|January 20, 1995
Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolinesW J Houlihan, P G Munder, D A Handley, et al.
British Medical Journal|September 13, 1975
Erythropoietic uroporphyria of Gunther first presenting at 58 years with positive family studiesR W Pain, F W Welch, A J Woodroffe, et al.
Journal of Medicinal Chemistry|October 15, 1993
Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonistsW J Houlihan, S H Cheon, V A Parrino, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 7, 2000
Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthmaD A Handley, D Tinkelman, M Noonan, et al.
Immunopharmacology|December 1, 1984
Effect of platelet activating factor on endothelial permeability to plasma macromoleculesD A Handley, C M Arbeeny, M L Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412D A Handley, R G Van Valen, M K Melden, et al.
Thrombosis and Haemostasis|April 7, 1987
In vitro and in vivo pharmacological profiles of the PAF receptor antagonist SRI 63-675D A Handley, R G Van Valen, C M Winslow, et al.
Pageof 7

Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
Mycologia|January 1, 1977
Strains of Fusidia which can be mistaken for ActinomycetesH Lechevalier, M P Lechevalier, D A Handley, et al.
Biochimica Et Biophysica Acta|April 15, 1988
Membrane-bound lipoprotein lipase on human monocyte-derived macrophages: localization by immunocolloidal gold techniqueI J Goldberg, D A Handley, T Vanni, et al.
Journal of Ultrastructure Research|April 1, 1983
Ultrastructural visualization of low-density lipoproteins during receptor binding and cellular endocytosisD A Handley, C M Arbeeny, L D Witte, et al.
Journal of Medicinal Chemistry|January 20, 1995
Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolinesW J Houlihan, P G Munder, D A Handley, et al.
British Medical Journal|September 13, 1975
Erythropoietic uroporphyria of Gunther first presenting at 58 years with positive family studiesR W Pain, F W Welch, A J Woodroffe, et al.
Journal of Medicinal Chemistry|October 15, 1993
Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonistsW J Houlihan, S H Cheon, V A Parrino, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 7, 2000
Dose-response evaluation of levalbuterol versus racemic albuterol in patients with asthmaD A Handley, D Tinkelman, M Noonan, et al.
Immunopharmacology|December 1, 1984
Effect of platelet activating factor on endothelial permeability to plasma macromoleculesD A Handley, C M Arbeeny, M L Lee, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1988
Biological effects of the orally active platelet activating factor receptor antagonist SDZ 64-412D A Handley, R G Van Valen, M K Melden, et al.
Thrombosis and Haemostasis|April 7, 1987
In vitro and in vivo pharmacological profiles of the PAF receptor antagonist SRI 63-675D A Handley, R G Van Valen, C M Winslow, et al.
Pageof 7